Financings Life science start-up companies raised a total of $1.8 billion in the first quarter of 2016, $579 million less than the previous quarter. Thirty-seven biopharma companies combined for $1.3
A significant economic milestone was passed by the small European nation of Norway two years ago. In January 2014, the central bank’s sovereign wealth fund exceeded NKr5.1 trillion (some $828 billion)
Early-stage Norwegian cardiovascular biomarker developer CardiNor AS has signed a deal with UK-based sheep monoclonal antibody company Bioventix Ltd. , which will supply antibodies for use in Car